Bck Capital Management »

Amicus Therapeutics shares owned by Bck Capital Management

Quarter-by-quarter ownership of Amicus Therapeutics (FOLD) shares owned by Bck Capital Management from 13F filings

Historical chart of Bck Capital Management investment in Amicus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Amicus Therapeutics held by Bck Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amicus Therapeutics by Bck Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $289k 20k 14.46

More positions owned by Bck Capital Management

M3brigade Acquisition V Corp Cl A (MBAV)
Cantor Equity Partners I Shs Cl A (CEPO)
Yorkville Acquisition Corp. Shs Cl A (MCGA)
Warner Bros Discovery Com Ser A (WBD)
Electronic Arts (EA)
Chart Industries (GTLS)
Hologic
Janus Henderson Group Ord Shs (JHG)
Arcellx Common Stock (ACLX)
AES Corporation (AES)
Sealed Air
UniFirst Corporation (UNF)
Albertsons Cos Common Stock (ACI)
Apellis Pharmaceuticals (APLS)
International Money Express (IMXI)

View all positions for Bck Capital Management

Top funds holding Amicus Therapeutics

BlackRock
Vanguard Group
UBS Group
State Street Corporation
Vanguard Capital Management
Pentwater Capital Management
Vanguard Portfolio Management
Glazer Capital
Goldman Sachs Group
Bellevue Group
HBK Investments
Geode Capital Management
Millennium Management
Morgan Stanley
CNH Partners

View all funds holding Amicus Therapeutics